四維圖新(002405.SZ):與北汽新能源簽署零部件開發合同
格隆匯7月7日丨四維圖新(002405.SZ)公佈,近日,北京四維圖新科技股份有限公司與北京新能源汽車股份有限公司(以下簡稱“北汽新能源”)簽署《零部件開發合同》,公司將爲北汽新能源兩車型開發泊車軟件產品。
四維圖新依託於自身高技術的研發團隊、豐富的零部件開發與製造經驗,爲北汽新能源某車型平臺開發泊車軟件產品。通過該開發成果生產製造的零部件,滿足北汽新能源終端客戶的持續、穩定、安全、舒適、便捷地使用車輛的需求。同時,雙方也旨在根據現有技術、開發成果,不斷改進、優化零部件及相關工藝技術。待四維圖新按約定完成產品開發工作並獲得北汽新能源書面認可後,雙方將另行協商確定由四維圖新向北汽新能源批量供貨事宜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.